Mechanistic insights into robust cardiac IKs potassium channel activation by aromatic polyunsaturated fatty acid analogues

  1. Briana M Bohannon
  2. Jessica J Jowais
  3. Leif Nyberg
  4. Vanessa Olivier-Meo
  5. Valentina Corradi
  6. D Peter Tieleman
  7. Sara I Liin
  8. H Peter Larsson  Is a corresponding author
  1. University of Miami, United States
  2. Linköping University, Sweden
  3. University of Calgary, Canada

Abstract

Voltage-gated potassium (KV) channels are important regulators of cellular excitability and control action potential repolarization in the heart and brain. KV channel mutations lead to disordered cellular excitability. Loss-of-function mutations, for example, result in membrane hyperexcitability, a characteristic of epilepsy and cardiac arrhythmias. Interventions intended to restore KV channel function have strong therapeutic potential in such disorders. Polyunsaturated fatty acids (PUFAs) and PUFA analogues comprise a class of KV channel activators with potential applications in the treatment of arrhythmogenic disorders such as Long QT Syndrome (LQTS). LQTS is caused by a loss-of-function of the cardiac IKs­­ channel - a tetrameric potassium channel complex formed by KV7.1 and associated KCNE1 protein subunits. We have discovered a set of aromatic PUFA analogues that produce robust activation of the cardiac IKs channel and a unique feature of these PUFA analogues is an aromatic, tyrosine head group. We determine the mechanisms through which tyrosine PUFA analogues exert strong activating effects on the IKs channel by generating modified aromatic head groups designed to probe cation-pi interactions, hydrogen bonding, and ionic interactions. We found that tyrosine PUFA analogues do not activate the IKs channel through cation-pi interactions, but instead do so through a combination of hydrogen bonding and ionic interactions.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1-6.

Article and author information

Author details

  1. Briana M Bohannon

    Department of Physiology and Biophysics, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  2. Jessica J Jowais

    Department of Physiology and Biophysics, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  3. Leif Nyberg

    Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
    Competing interests
    No competing interests declared.
  4. Vanessa Olivier-Meo

    Department of Physiology and Biophysics, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  5. Valentina Corradi

    Department of Biological Sciences, University of Calgary, Calgary, Canada
    Competing interests
    No competing interests declared.
  6. D Peter Tieleman

    Department of Biological Sciences, University of Calgary, Calgary, Canada
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5507-0688
  7. Sara I Liin

    Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
    Competing interests
    Sara I Liin, A patent application (#62/032,739) including a description of the interaction of charged lipophilic compounds with the KCNQ1 channel has been submitted by the University of Miami with HPL and SIL identified as inventors..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8493-0114
  8. H Peter Larsson

    Department of Physiology and Biophysics, University of Miami, Miami, United States
    For correspondence
    plarsson@med.miami.edu
    Competing interests
    H Peter Larsson, A patent application (#62/032,739) including a description of the interaction of charged lipophilic compounds with the KCNQ1 channel has been submitted by the University of Miamiwith HPL and SIL identified as inventors.Dr Hans Peter Larsson is the equity owner of VentricPharm, a company that operates in the same field of research as the study..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1688-2525

Funding

HORIZON EUROPE European Research Council (850622)

  • Sara I Liin

Swedish Research Council (2021-01885)

  • Sara I Liin

National Institutes of Health (R01HL131461)

  • H Peter Larsson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Teresa Giraldez, University of La Laguna, Spain

Version history

  1. Received: December 22, 2022
  2. Preprint posted: January 16, 2023 (view preprint)
  3. Accepted: June 22, 2023
  4. Accepted Manuscript published: June 23, 2023 (version 1)
  5. Version of Record published: July 7, 2023 (version 2)

Copyright

© 2023, Bohannon et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 563
    views
  • 73
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Briana M Bohannon
  2. Jessica J Jowais
  3. Leif Nyberg
  4. Vanessa Olivier-Meo
  5. Valentina Corradi
  6. D Peter Tieleman
  7. Sara I Liin
  8. H Peter Larsson
(2023)
Mechanistic insights into robust cardiac IKs potassium channel activation by aromatic polyunsaturated fatty acid analogues
eLife 12:e85773.
https://doi.org/10.7554/eLife.85773

Share this article

https://doi.org/10.7554/eLife.85773

Further reading

    1. Structural Biology and Molecular Biophysics
    Abdul Wasim, Sneha Menon, Jagannath Mondal
    Research Article

    Intrinsically disordered protein α-synuclein (αS) is implicated in Parkinson’s disease due to its aberrant aggregation propensity. In a bid to identify the traits of its aggregation, here we computationally simulate the multi-chain association process of αS in aqueous as well as under diverse environmental perturbations. In particular, the aggregation of αS in aqueous and varied environmental condition led to marked concentration differences within protein aggregates, resembling liquid-liquid phase separation (LLPS). Both saline and crowded settings enhanced the LLPS propensity. However, the surface tension of αS droplet responds differently to crowders (entropy-driven) and salt (enthalpy-driven). Conformational analysis reveals that the IDP chains would adopt extended conformations within aggregates and would maintain mutually perpendicular orientations to minimize inter-chain electrostatic repulsions. The droplet stability is found to stem from a diminished intra-chain interactions in the C-terminal regions of αS, fostering inter-chain residue-residue interactions. Intriguingly, a graph theory analysis identifies small-world-like networks within droplets across environmental conditions, suggesting the prevalence of a consensus interaction patterns among the chains. Together these findings suggest a delicate balance between molecular grammar and environment-dependent nuanced aggregation behavior of αS.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Sandeep K Ravala, Sendi Rafael Adame-Garcia ... John JG Tesmer
    Research Article

    PIP3-dependent Rac exchanger 1 (P-Rex1) is abundantly expressed in neutrophils and plays central roles in chemotaxis and cancer metastasis by serving as a guanine-nucleotide exchange factor (GEF) for Rac. The enzyme is synergistically activated by PIP3 and heterotrimeric Gβγ subunits, but mechanistic details remain poorly understood. While investigating the regulation of P-Rex1 by PIP3, we discovered that Ins(1,3,4,5)P4 (IP4) inhibits P-Rex1 activity and induces large decreases in backbone dynamics in diverse regions of the protein. Cryo-electron microscopy analysis of the P-Rex1·IP4 complex revealed a conformation wherein the pleckstrin homology (PH) domain occludes the active site of the Dbl homology (DH) domain. This configuration is stabilized by interactions between the first DEP domain (DEP1) and the DH domain and between the PH domain and a 4-helix bundle (4HB) subdomain that extends from the C-terminal domain of P-Rex1. Disruption of the DH–DEP1 interface in a DH/PH-DEP1 fragment enhanced activity and led to a more extended conformation in solution, whereas mutations that constrain the occluded conformation led to decreased GEF activity. Variants of full-length P-Rex1 in which the DH–DEP1 and PH–4HB interfaces were disturbed exhibited enhanced activity during chemokine-induced cell migration, confirming that the observed structure represents the autoinhibited state in living cells. Interactions with PIP3-containing liposomes led to disruption of these interfaces and increased dynamics protein-wide. Our results further suggest that inositol phosphates such as IP4 help to inhibit basal P-Rex1 activity in neutrophils, similar to their inhibitory effects on phosphatidylinositol-3-kinase.